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SUMMARY
Various biomarkers of exposure have been explored as a way to quantitatively estimate an internal 
dose of manganese (Mn) exposure, but given the tight regulation of Mn in the body, inter-
individual variability in baseline Mn levels, and variability in timing between exposure and uptake 
into various biological tissues, identification of a valuable and useful biomarker for Mn exposure 
has been elusive. Thus, a mixed model estimating variance components using restricted maximum 
likelihood was used to assess the within- and between-subject variance components in whole 
blood, plasma, and urine (MnB, MnP, and MnU, respectively) in a group of nine newly-exposed 
apprentice welders, on whom baseline and subsequent longitudinal samples were taken over a 
three month period. In MnB, the majority of variance was found to be between subjects (94%), 
while in MnP and MnU the majority of variance was found to be within subjects (79% and 99%, 
respectively), even when controlling for timing of sample. While blood seemed to exhibit a 
homeostatic control of Mn, plasma and urine, with the majority of the variance within subjects, 
did not. Results presented here demonstrate the importance of repeat measure or longitudinal 
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study designs when assessing biomarkers of Mn, and the spurious associations that could result 
from cross-sectional analyses.
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INTRODUCTION
Elevated Mn exposures have long been an occupational health concern, as chronic elevated 
exposures have been implicated in the development of “manganism”, a Parkinson’s-like 
syndrome [1]. However, even workers with exposures considerably lower than those 
historically associated with manganism have demonstrated subtle neurological effects, 
making Mn a relevant occupational and environmental health concern [2–5].
Various biomarkers of exposure have been explored as a way to quantitatively estimate an 
internal dose of Mn. In a literature-based analysis of the relationship between manganese in 
whole blood (MnB) and manganese in air (MnA) we hypothesised that there may be a point 
above which blood begins to act as a biomarker of inhalation exposure to Mn, but this still 
requires additional time-specific analyses, and knowledge of non-occupational exposure to 
Mn and its physiological variability in absorption or excretion [6]. For some biological 
media, notably Mn in plasma (MnP) and Mn in urine (MnU), limits of detection could be 
problematic. Hoet et al. [7] found 80% of control and 65% of welder urine samples to be 
below their limit of quantification (0.20 ng/mL) for MnU, making further analysis 
impossible. The majority of biomarker studies related to occupational inhalation of Mn are 
cross-sectional, typically only analysing a single biosample. Only a few studies have looked 
at biomarkers of Mn longitudinally or with repeat measures, [7–11] but none have 
thoroughly assessed the within-individual or between-individual variability components. 
Järvisalo et al. [11] briefly discussed the variability in six MnU measurements taken over a 
24 hour period in five shielded metal arc welding (SMAW) welders, noting that Mn showed 
diurnal variation throughout the day, with lower MnU values tending toward the late 
afternoon or evening, even with increased exposure to Mn over the workday. However, no 
formal assessment of variability components was carried out in this manuscript.
In proposing a framework for developing and applying biological guidance values, Bevan et 
al. [12] recommended that inter- and intra-variability in biomarker measurements be 
considered when developing guidelines for a specific chemical. However, often these data 
are not available. Similarly, Albertini et al. [13] in a mini-monograph called for research to 
advance the understanding of biomonitoring to assess human exposure and health risks and 
specifically study designs to better assess variance components in biomonitoring 
measurements.
The assessment of variance components and exploration of which external factors may 
affect them can help to better characterise relationships between exposure, dose, and effects. 
Thus, the purpose of this manuscript is to investigate the factors associated with variability 
in MnB, MnP, and MnU in a newly-exposed group of apprentice welders.
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MATERIAL AND METHODS
Occupational setting and study population
The focus of this manuscript is nine welder trainees enrolled in a technical college in 
Washington state, who are a subset of a larger inception cohort study (that is, all subjects 
joined our cohort prior to any reported occupational exposure to Mn) which we have 
described elsewhere [6]. All study protocols were reviewed and approved by the University 
of Washington Institutional Review Board and subjects provided written informed consent. 
Data collection for the inception cohort study began in April 2011, but this manuscript is 
restricted to nine welder trainees in the first academic quarter (September 2012—December 
2012) of their traineeship, who entered the welding training program with no prior welding 
experience or reported occupational exposure to Mn.
The welding training program consists of five academic quarters, where students progress 
through a schedule of different welding processes, though time on each process may vary 
between subjects. While the nine trainees described here were followed for all five academic 
quarters, this analysis is restricted to their first academic quarter period of study. During this 
first quarter of the program, all nine trainees started with oxyacetylene welding (very low 
Mn exposure) before progressing to SMAW (moderate Mn exposure) after about a months’ 
time. Trainees were in class Monday through Friday, with time split between welding 
practice and classroom lectures. Each welding booth in the facility has a dedicated 
adjustable exhaust ventilation hood to control fume, and trainees were given the choice 
whether or not to wear respiratory protection. No subjects wore respiratory protection while 
doing oxyacetylene welding, but six of the nine subjects (66.7%) consistently wore 
respiratory protection during SMAW welding.
Trainees were asked to provide a baseline blood and urine sample on the morning of their 
first day enrolled in the traineeship (a Tuesday), and at seven additional times over the 
course of their first quarter: the afternoon of their first day, the morning and afternoon of 
their first Friday, the morning and afternoon of their last Monday of the quarter, and the 
morning and afternoon of their last Friday of the quarter. On each biosampling day, subjects 
were also fitted with a personal air pump for the entire school day to measure airborne 
exposure to Mn. At the end of each biosampling day, trainees completed a questionnaire to 
assess their welding activity, use of respiratory protection, and any confounding sources of 
Mn exposure.
Demographic and work characteristics for these nine trainees are summarized in Table 1. 
Measured total Mn concentration in the air (total suspended particles) were normalized to 
eight-hour time weighted averages (TWA) and Mn exposure from SMAW welding was on 
average about 10 times higher than from oxyacetylene welding. No oxyacetylene or SMAW 
exposure measurements exceeded the National Institute for Occupational Safety and Health 
(NIOSH) eight hour TWA recommended exposure limit (REL) of 1 mg/m3. However, based 
on self-report, subjects welded on average less than 4 hours each work day (221.2 ± 81.8 
minutes).
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Blood Mn analysis
At the beginning and end of sampling days, 6 mL of whole blood were collected in plastic 
Vacutainer® evacuated tubes containing 10.8 mg K2EDTA anticoagulant (BD, Franklin 
Lakes, NJ) and transported on ice to University of Washington Environmental Health 
Laboratory (UW EHL). One mL of whole blood was transferred to a 15 mL Corning 
CentriStar polypropylene centrifuge tube (Corning, NY) and stored at 4 degrees C until 
analysis for trace metals. Microwave assisted acid digestion prepared samples for 
multielement analysis of whole blood by ICP-MS (Agilent 7500 CE) [14]. A control 
material (ClinChek Level 1 Whole Blood Control, lyophilised for trace elements (Lot 038), 
Recipe Chemicals, Munich, Germany) was analysed periodically. The results obtained for 
Mn in ClinChek materials were within the manufacturer’s acceptable reference range of 5.6
—8.4 ng/mL (found mean test value 7.3 ng/mL, SD: 0.1 ng/mL, n=6). The limit of detection 
for Mn was 0.5 µg/L, and is based on three times the standard deviation of the analysis-
batch-specific field blanks. Limit of quantification for Mn in blood (10 times the standard 
deviation of the blanks) was 1.7 µg/L. No blood samples fell below the limit of detection or 
limit of quantification for Mn.
Plasma Mn analysis
The remaining whole blood was centrifuged for 20 minutes at 600 CFM to allow for the 
extraction of 1 mL plasma, which was pipetted into 2.0 mL Eppendorf tubes (Hauppauge, 
New York). Aliquoted plasma samples were sent on dry ice for analysis at the UK Health 
and Safety Laboratory (HSL, Harpur Hill, Buxton, UK) where instrumentation allowed for 
an improved limit of detection compared to the UW EHL. Samples were still frozen upon 
arriving at HSL, and were stored at 4 degrees until analysis for trace metals. The samples 
were diluted twenty-fold and analysed using ICP-MS (Thermo X Series 2) in collision cell 
gas mode. The instrument was calibrated 0.05—20 ng/mL for Mn. Certified reference 
materials (Seronorm serum CRM Levels 1 (Lot 0903106) and 2 (Lot 0903107), Sero, 
Billingstad, Norway) and a check standard were analysed periodically throughout the 
analysis. The results obtained for Mn in Seronorm serum were on average within the 
manufacturer’s acceptable reference range of 14.1—15.9 ng/mL (found mean test value 
15.17, SD: 0.52, n=6) for Level 1, and on average within the manufacturer’s acceptable 
reference range of 18.8—21.0 ng/mL (found mean test value 20.4, SD: 0.66, n=6) for Level 
2. Given there are no plasma certified reference materials for trace elements, a blank and a 
spiked plasma sample were analysed as well as a spiked serum sample at the start and end of 
the analysis and after every ten samples. Mean spiked plasma recovery for Mn was 113.2% 
SD: 18.0%. Limit of detection for Mn was 0.005 µg/L, and is three times the standard 
deviation of the blanks. Limit of quantification for Mn in plasma (10 times the standard 
deviation of the blanks) was 0.017 µg/L. No plasma samples fell below the limit of detection 
or limit of quantification for Mn.
Urine Mn analysis
At the beginning and end of each sampling day, subjects were asked to provide a sample of 
urine, collected in a 4 oz. low-density polyethylene wide mouth bottle. (Fisherbrand, 
Pittsburgh, PA). 5 mL samples were aliquoted into 15 mL Corning CentriStar polypropylene 
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centrifuge tubes (Corning, NY) and sent on dry ice for analysis at HSL, where 
instrumentation allowed for an improved limit of detection compared to UW EHL. Samples 
were still frozen upon arrival at HSL, and remained frozen until analysis. Creatinine 
measurements were undertaken, and the samples were diluted twenty-fold and analysed 
using ICP-MS (Thermo X Series 2) in collision cell gas mode. The instrument was 
calibrated 0.05—10 ng/mL for Mn. Control materials (ClinChek Levels 1 and 2 Lot: 122, 
Recipe, Germany) and a check standard were analysed throughout the analysis. The results 
obtained for Mn in ClinChek were within the manufacturer’s acceptable reference range of 
3.34—5.02 ng/mL (found mean test value 4.09, SD: 0.07, n=5) for Level 1, and within the 
manufacturer’s acceptable reference range of 15.8—23.6 ng/mL (found mean test value 
19.3, SD: 0.42, n=5) for Level 2. The limit of detection for Mn was 0.038 µg/L and is based 
on three times the standard deviation of the blanks. Eighteen of the 63 urine samples 
(28.6%) fell below the limit of detection. The limit of quantification for Mn in urine (10 
times the standard deviation of the blanks) was 0.13 µg/L. Forty-four of the 63 urine samples 
(69.8%) fell below the limit of quantification. For all subsequent analyses, urine samples 
were creatinine corrected.
Statistical methods
Plasma and blood data were determined to be log normally distributed, and thus were log-
transformed for analysis. In all subsequent analyses, the urine samples that fell below the 
LOD were treated two different ways in mixed models to assess variability components. 
First, they were replaced with the LOD/  [15] and normalized to a creatinine concentration 
of 1 g/L by dividing the measured Mn concentration (in µg/L) by its measured creatinine 
concentration (in mg/mL). Resultant units of the creatinine corrected urine values are thus 
µg Mn/g creatinine, which were then log transformed yielding the units of ln(µg Mn/g 
creatinine). Secondly, values that fell below the LOD were imputed using multiple 
imputation interval regression. This form of multiple imputation can be used with censored 
data, and imputes values in a specified interval (in our case, below the LOD but greater than 
0) assuming the distribution of the censored data is similar to the distribution of the 
uncensored data [16]. Multiple imputation can be a strong tool for missing data (or in our 
case, data below the LOD) as it maintains features of the whole data set, such as variances, 
means, or correlations between variables used in the imputation model [17].
Uncorrected urine values below the LOD of 0.038 µg/L were flagged as left censored. A 
multiple imputation interval regression specifying an upper limit of 0.038 µg/L and lower 
limit of 0 was used to generate 20 imputed data sets, each with 45 original values and 18 
imputed values below the LOD. The multiple imputation interval regression included 
subject, respirator use (yes or no) and temporal characteristics of the urine sample (morning 
vs. afternoon, beginning of quarter vs. end of quarter, and beginning of week vs. end of 
week) in the model. Welding type was not included in the model, as all subjects were doing 
the same type of welding on each sampling day—oxyacetylene on both days at the 
beginning of the quarter, and SMAW on both days at the end of the quarter. These 20 data 
sets with imputed values were then creatinine corrected and log-transformed prior to 
additional analyses. For descriptive purposes, the mean of all 20 log transformed and 
creatinine corrected imputed values is what is considered for each value that was originally 
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below the LOD, but for the restricted maximum likelihood regression (REML) analyses to 
assess variability components, all 20 imputed data sets were considered, with individual 
point estimates combined, and standard errors estimated based on Rubin’s Rules for multiple 
imputation [18].
A mixed model estimating variance components using REML was used to assess the 
variance components in MnB, MnP, and MnU, including subject as a random effect and 
time of the sample (morning vs. afternoon, beginning of quarter vs. end of quarter, and 
beginning of week vs. end of week) and use of respiratory protection (yes or no) as fixed 
effects. For temporal variables, the beginning of the day, beginning of the week, and 
beginning of the quarter were the reference groups (coded as 0). Temporal measures were 
included in the model as surrogate measures of exposure, since exposures are assumed to 
increase over the course of a day, week, and quarter. Moreover, including time of day in the 
model also accounts for dirurnal variation in Mn at the physiological level, such as that seen 
by Järvisalo et al. [11]. All statistical analyses were done in Stata 12 (College Park, TX). 
While we do have actual measured Mn exposure, analysis of the relationship between Mn in 
air and Mn in blood for the full cohort will be presented in a future manuscript.
RESULTS
Descriptive statistics for MnB, MnP, and MnU are presented in Table 2, stratified by the 
beginning and end of each temporal period in question: day, week, and quarter. Over the 
course of a week, geometric mean MnP shows a significant decrease (p=0.006), and while 
MnP also tends to decrease over the course of a day, congruent with what Järvisalo saw in 
MnU, this decrease is not significant. Geometric mean MnB showed no significant changes 
over a day, week, or quarter, nor did geometric mean MnU both when values below the 
LOD were replaced with LOD/√2 and imputed using interval regression. Imputing MnU data 
(and then taking the mean of the data sets for the descriptives) resulted in lower geometric 
mean MnU for all time points compared to the MnU data in which values under the LOD 
were replaced with LOD/√2. This is logical since the lower limit of the imputed values was 
allowed to approach zero prior to adjusting for creatinine. Similarly, the imputed MnU data 
has larger geometric standard deviations than the replaced MnU data, which can likely be 
attributed to the increased range (on the lower end) and spread of the imputed data compared 
to the replaced data.
Table 3 shows the distribution of urine samples that fell below the LOD, stratified by time of 
sample, comparing AM samples to PM samples, start of the week samples to end of the 
week samples, and start of quarter samples to end of quarter samples. Using a Pearson’s chi-
squared test, no significant difference in the proportion of samples that fell below the LOD 
was observed when considering changes over the various exposure periods; though when 
considering the proportion under the LOD at the start of the quarter vs. the end of the 
quarter, there was a marginally significant difference (p=0.056). However, when stratifying 
MnU values by beginning of quarter and end of quarter, there was no significant difference 
between the geometric means, using a two-tailed t test.
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Table 4 shows the within-individual and between-individual variance components from the 
mixed model (also shown graphically in Figure 1 for MnB, MnP, and MnU with censored 
data treated both ways), in addition to coefficients for the fixed effects included in the 
model. Temporal elements (time of day, week, quarter) and respiratory protection were 
included as fixed effects in the mixed models, with subject being included as a random 
effect. In the mixed models using REML to estimate variance components for MnP, time of 
week (beginning of week vs. end of week) was a significant contributor to the model 
(p=0.003), suggesting a 19.3% (95% CI: 6.36%, 33.8%) higher geometric mean in samples 
taken at the beginning of the week compared to samples taken at the end of the week. This is 
consistent with the descriptive statistics presented in Table 2. For MnB, none of the 
temporal variables or the use of respiratory protection were significant contributors to the 
mixed model. Similarly, when considering MnU both imputed and replaced with LOD/√2, 
none of the temporal variables or the use of respiratory protection were significant 
contributors to the mixed model.
When considering creatinine corrected urine values below the LOD as 0.038 µg/L , 
nearly all of the variance in MnU is within the individual (>99.99%) with only a fraction of 
a percent (<0.01%) being due to differences between individuals. When using interval 
regression multiple imputation to predict creatinine corrected MnU values below the LOD, 
the total variance in the data increased to 2.14 from 1.34, but was still nearly all within the 
individual. The increase in total variance can, again, likely be attributed to the increased 
range and spread of the data, due to enough values below the LOD being imputed to a range 
bounded by zero and LOD prior to being creatinine corrected, instead of all being given the 
same value prior to creatinine correction. Like MnU, MnP also exhibits more variability 
within the individual (78.79%) than between individuals (21.21%); however not as starkly 
contrasted as in urine. Considering MnB, nearly all of the variability (93.69%) is between 
individual, with only 6.31% being within individual, making blood the only biological 
component considered with the majority of variance being between individuals as opposed 
to within the individual.
DISCUSSION
This is the first manuscript to address within and between subject variance components of 
MnB, MnP, and MnU in a well-characterized longitudinal cohort. From a mixed-model 
using REML to estimate variances, we observed different partitioning of variability 
components in different biological media. This would influence which biological media to 
use as a biomarker of exposure, how to interpret the data, and methods to best collect the 
specimen. The trainees’ eight hour TWA exposure levels for Mn (even when SMAW 
welding) were on the low end compared to reported eight hour TWA exposures for welders 
in industry settings [19–24], and when compared to workers employed in other Mn-utilizing 
industries such as smelting [25, 26], or ferroalloy production [27, 28]. However, despite 
their comparatively low exposures, the trainees’ exposures did exceed environmental 
background levels, and thus we considered temporal elements as a surrogate measure of 
exposure in all mixed-models, assuming exposures would increase over the course of a day, 
week, and quarter. Therefore, any variance between subjects would be due less to 
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differences in exposures, and more to unmeasured subject-specific variables which were not 
accounted for in these analyses.
In blood, we found nearly all the variability in Mn to be between subjects, meaning that 
repeat measurements on a given subject tended to be fairly similar to the baseline 
measurement. Thus, for subjects in our study, a single blood measurement gave a reliable 
measure of the subject’s MnB at other time points, which could be indicative of a 
homeostatic regulation of Mn in the blood, at least at the low Mn exposure levels our 
subjects experienced in this study. The baseline MnB for our nine subjects ranged from 4.95 
µg/mL to 13.40 µg/mL, a range of 8.45 µg/mL. While between-subject differences in dietary 
exposure to Mn may provide a possible explanation for the observed subject-specific 
differences in average MnB, dietary intake of Mn is likely to vary substantially over time. 
Thus, it seems unlikely that this explanation would simultaneously account for both the low-
within subject variability in MnB, and the unique subject-specific average MnB values that 
we observe. The low within subject variability of MnB, in combination with the high within-
subject variability in MnU and MnB suggest tight homeostatic control of MnB. Given that 
all subjects entered our study with no previous reported exposure to occupational Mn, it is 
possible that a yet-to-be-determined physiologic or metabolic difference between the 
subjects that is driving the observation that each subject has a unique average MnB.
Given our low levels of exposure, it is interesting to hypothesise how our results could be 
extrapolated to workers with higher exposures to Mn. Workers with higher average 
exposures, especially those working in traditional settings as opposed to training classrooms, 
are likely to have greater between-subject variability in exposure as compared to our 
trainees, as they would be doing tasks different from each other, but similar day-to-day. This 
could reinforce the between-subject component for variability in MnB. However, if Mn 
exposure became high enough, the homeostatic regulation of MnB we observed in our 
inception cohort could be overcome, and thus the within-person variability would increase. 
However, it is as-yet unknown if the point where homeostatic control is overcome would be 
similar for all people, or if subjects with higher baseline Mn would reach that point before 
subjects with a lower baseline Mn. If so, baseline Mn could play a role in predicting workers 
more susceptible to adverse health outcomes associated with Mn exposure.
Plasma was the only biological media to show a significant change in Mn concentration with 
any of our measures of temporality, with plasma samples taken at the end of a week (Friday) 
being significantly lower than those taken at the beginning of the week. This observation 
runs counter to our a priori hypothesis, since the welders would presumably experience an 
increase in cumulative Mn exposure over the course of a work week. Diurnal variations are 
common in many human physiological processes, but in our sample we did not see a 
significant decrease over the course of a day in MnP or MnU like those observed by 
Järvisalo [11].
Both MnP and MnU showed the majority of variability to be within subjects as opposed to 
between subjects. This partitioning of variance can be interpreted to mean that multiple 
measurements on a single subject are apt to show a large degree of variation, and a single 
sample isn’t necessarily representative of an individual’s MnU or MnP concentration at any 
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other time point, even when controlling for exposure. Given the majority of the variance in 
these media is within a subject, comparing a single MnP or MnU measurement to a single 
external exposure value, as is common in the largely cross-sectional studies of biomarkers of 
Mn reported in the literature, could be misleading. Additionally, unlike MnB, it could be 
difficult to calculate a meaningful change in MnP or MnU values even if a baseline 
measurement is available, since it would be hard to determine if a change is related to actual 
changes in exposure, internal physiologic or metabolic factors, or periodicity. For these 
reasons, in addition to the LOD factors present with MnU, interpretation of urine and plasma 
as biomarkers of Mn remains challenging.
It is physiologically unclear why MnB exhibits the majority of variance between subjects 
and MnP and MnU exhibit the majority of variance within subjects. One possibility could be 
the apparent homeostatic regulation of MnB. When additional inhaled or ingested Mn is 
deposited in the blood may be quickly removed and transported via the plasma into the urine 
(perhaps as a negative feedback mechanism), thus making MnB levels more stable and MnP 
and MnU levels more variable within a subject. Mn is known to complex with other 
substances in the plasma for transport [29, 30]. Animal studies have found that these plasma 
transporters used by Mn are also used by other metals such as iron, copper, or zinc [31–33]. 
Thus, co-exposures to these metals could explain some of the within-subject variation in 
MnP levels due to the competition for transporter binding. In a cross-sectional study of Mn-
exposed ferroalloy smelter workers, Cowan et al. found that an increase in Mn exposure 
yielded a general decrease in iron levels in various blood compartments, hypothesizing that 
this inverse relationship may be due to increased competition for binding sites [26]. Further, 
these authors found that calculating a Mn to iron ratio in both plasma and erythrocytes was a 
useful biomarker to distinguish Mn-exposed workers from unexposed referents. However, 
even in the unexposed controls, many subjects in the Cowan et al. study had MnP levels on 
the order of 10 to 100 times higher than those presented in this manuscript, and the cross-
sectional nature of the study did not allow Cowan et al. to calculate within-subject variation 
in any of the myriad biomarkers they measured.
Additionally, the increased within-subject variability in plasma and especially urine could be 
due to analytic variability, since Mn concentrations are much lower and closer to the LOD in 
these media than in blood. Similarly, our data exhibited a high MnB to MnP ratio, so 
hydrolysis of even a small fraction of the red blood cells during the blood draw or laboratory 
separation could dramatically increase MnP. Circadian and seasonal rhythms could also play 
a role in MnP levels to a greater extent than MnB levels, and our measures of temporality 
were too crude to address these measures of variability. Touitou et al. [34] found that 
proteins in plasma followed circadian and seasonal variations, even when controlling for 
changes in the whole blood such as red blood cell count, haematocrit, and haemoglobin. 
Because Mn may be protein-bound in the plasma, variations in levels of the proteins that 
bind Mn in the plasma could logically lead to variations in the levels of Mn in the plasma, as 
well.
Our analysis has several limitations which could be improved upon in future studies. First, 
our subjects were exposed to fairly low levels of Mn in welding fume over the three month 
study period, making inference from our results to typical occupationally exposed 
Baker et al. Page 9
J Trace Elem Med Biol. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
populations difficult. In a previous manuscript we provided evidence that there is a threshold 
above which inhalation exposures are high enough to overcome internal regulation or 
dietary background, and a relationship between Mn exposure and MnB is apparent [6]. This 
threshold was around 10µg/m3—a Mn exposure level higher than what our welder trainees 
were exposed to during oxyacetylene welding but generally lower than what they were 
exposed to during SMAW. If this is the case, then perhaps with sustained exposure above 
this threshold the subject-specific mean MnB would increase. The within-subject variance 
component of MnB may also increase, due to either the greater exposure variability, or the 
higher Mn exposure overcoming the body’s homeostatic control of MnB.
In the urine data, the nearly 30% of values that fell below the LOD were (1) replaced with 
the LOD/√2 or (2) imputed using interval regression. Replacing nearly 30% of the data with 
the same value could artificially decrease total variance in the sample, while imputing values 
to zero could artificially increase total variance in the sample compared to what the actual 
values would yield. However, barring improvements to analytical equipment or assay 
procedures, the handling of values below the LOD with either replacement or imputation is 
likely unavoidable in studies dealing with low levels of MnU as observed in this study. 
Using replacement vs. imputation with our data did little to change point estimates or 
estimates of variance partitioning, though imputation did increase total variation in the 
sample, as would be expected. Knowing the variance components in MnB, MnU, and MnP 
in a study of only environmentally exposed persons would also help inform this analysis, 
however, that has not been explored in the literature.
CONCLUSIONS
This study represents the first time that variance components of MnU, MnP, and MnB have 
been explored in the literature. Our findings show that Mn seems to be fairly tightly 
regulated in the blood, at least at the low and short term exposures experienced in this study, 
which does not appear to be the case when considering Mn in plasma or urine. Both MnU 
and MnP exhibited the majority of variance within the individual, meaning a single sample 
of these biofluids may not be representative of a person’s MnU or MnP concentration at any 
other time point, making comparisons to occupational exposures or a health outcome 
challenging and uninformative. Under the conditions experienced in our study (that is, low 
exposure, short duration) a single blood measurement adequately reflects MnB in a given 
subject. Thus, going forward, we need to better elucidate what factors may influence the as 
yet unexplained subject-specific differences observed in baseline MnB, and what factors 
may influence the variable MnP and MnU measurements observed in a subject over short 
time periods.
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Figure 1. Biological measures of Mn exposure, by subject
Log-transformed biological measures of Mn exposure, by subject for (A) ln MnB (µg/L), (B) 
ln MnP (µg/L), (C) ln MnU with values below the LOD replaced with 0.038/√2 (µg Mn/g 
creatinine), and (D) ln MnU with values below the LOD imputed using interval regression 
multiple imputation (µg Mn/g creatinine).
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Table 1
Subject demographic and exposure characteristics
n 9
Age (years) 22.1 ± 2.9
Male, n (%) 9 (100)
Current Smoker, n (%) 1 (11.1)
Respirator User, n (%) 6 (66.7)
Time welding/day (mins) 221 ± 82
Oxy welding 8 hr TWA Mn 3.6 ± 3.5 µg/m3
SMAW welding 8 hr TWA Mn 39 ± 46 µg/m3
n blood samples/subject 7.1 ± 1.1
n plasma samples/subject 6.9 ± 1.4
n urine samples/subject 7.0 ± 1.2
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Table 3
MnU measurements below the LOD
# below LOD p*
AM 11 (35.5%)
0.23
PM 7 (21.9%)
Start Week 8 (26.7%)
0.75
End Week 10 (30.3%)
Start quarter 6 (18.2%)
0.06
End quarter 12 (40.0%)
*
Pearson's chi-squared
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